Inflammatory response time course, HUVEC (Wada et al., 2009)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
NR1I2
|
ENSG00000144852.12 | nuclear receptor subfamily 1 group I member 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NR1I2 | hg19_v2_chr3_+_119501557_119501557 | -0.13 | 5.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr13_+_32605437 | 5.63 |
ENST00000380250.3
|
FRY
|
furry homolog (Drosophila) |
chr3_+_8543393 | 5.13 |
ENST00000157600.3
ENST00000415597.1 ENST00000535732.1 |
LMCD1
|
LIM and cysteine-rich domains 1 |
chr3_+_8543561 | 4.39 |
ENST00000397386.3
|
LMCD1
|
LIM and cysteine-rich domains 1 |
chr6_+_142622991 | 4.08 |
ENST00000230173.6
ENST00000367608.2 |
GPR126
|
G protein-coupled receptor 126 |
chr8_-_93115445 | 4.01 |
ENST00000523629.1
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr6_+_142623063 | 3.92 |
ENST00000296932.8
ENST00000367609.3 |
GPR126
|
G protein-coupled receptor 126 |
chr1_+_61869748 | 3.73 |
ENST00000357977.5
|
NFIA
|
nuclear factor I/A |
chr1_+_25944341 | 3.64 |
ENST00000263979.3
|
MAN1C1
|
mannosidase, alpha, class 1C, member 1 |
chr9_-_14313641 | 3.40 |
ENST00000380953.1
|
NFIB
|
nuclear factor I/B |
chr10_-_131762105 | 3.38 |
ENST00000368648.3
ENST00000355311.5 |
EBF3
|
early B-cell factor 3 |
chr3_+_8543533 | 3.34 |
ENST00000454244.1
|
LMCD1
|
LIM and cysteine-rich domains 1 |
chr9_-_14314066 | 3.15 |
ENST00000397575.3
|
NFIB
|
nuclear factor I/B |
chr10_-_33625154 | 3.09 |
ENST00000265371.4
|
NRP1
|
neuropilin 1 |
chr6_+_84743436 | 2.98 |
ENST00000257776.4
|
MRAP2
|
melanocortin 2 receptor accessory protein 2 |
chr4_-_149363662 | 2.97 |
ENST00000355292.3
ENST00000358102.3 |
NR3C2
|
nuclear receptor subfamily 3, group C, member 2 |
chr12_-_96184533 | 2.96 |
ENST00000343702.4
ENST00000344911.4 |
NTN4
|
netrin 4 |
chr18_+_3466248 | 2.95 |
ENST00000581029.1
ENST00000581442.1 ENST00000579007.1 |
RP11-838N2.4
|
RP11-838N2.4 |
chr9_-_14313893 | 2.88 |
ENST00000380921.3
ENST00000380959.3 |
NFIB
|
nuclear factor I/B |
chr3_+_193853927 | 2.60 |
ENST00000232424.3
|
HES1
|
hes family bHLH transcription factor 1 |
chr14_-_90085458 | 2.56 |
ENST00000345097.4
ENST00000555855.1 ENST00000555353.1 |
FOXN3
|
forkhead box N3 |
chr9_-_134151915 | 2.29 |
ENST00000372271.3
|
FAM78A
|
family with sequence similarity 78, member A |
chr4_+_30721968 | 2.19 |
ENST00000361762.2
|
PCDH7
|
protocadherin 7 |
chr10_-_125851961 | 2.18 |
ENST00000346248.5
|
CHST15
|
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
chr1_+_25943959 | 2.18 |
ENST00000374332.4
|
MAN1C1
|
mannosidase, alpha, class 1C, member 1 |
chr11_-_118122996 | 2.04 |
ENST00000525386.1
ENST00000527472.1 ENST00000278949.4 |
MPZL3
|
myelin protein zero-like 3 |
chr15_-_65067773 | 2.03 |
ENST00000300069.4
|
RBPMS2
|
RNA binding protein with multiple splicing 2 |
chr2_+_69240302 | 1.98 |
ENST00000303714.4
|
ANTXR1
|
anthrax toxin receptor 1 |
chr8_+_37654424 | 1.98 |
ENST00000315215.7
|
GPR124
|
G protein-coupled receptor 124 |
chr4_-_159080806 | 1.88 |
ENST00000590648.1
|
FAM198B
|
family with sequence similarity 198, member B |
chr5_-_133747589 | 1.84 |
ENST00000458198.2
|
CDKN2AIPNL
|
CDKN2A interacting protein N-terminal like |
chr15_+_96875657 | 1.83 |
ENST00000559679.1
ENST00000394171.2 |
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
chr5_+_73109339 | 1.77 |
ENST00000296799.4
|
ARHGEF28
|
Rho guanine nucleotide exchange factor (GEF) 28 |
chr10_+_94833642 | 1.69 |
ENST00000224356.4
ENST00000394139.1 |
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1 |
chr3_-_183735731 | 1.66 |
ENST00000334444.6
|
ABCC5
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
chr4_-_159094194 | 1.65 |
ENST00000592057.1
ENST00000585682.1 ENST00000393807.5 |
FAM198B
|
family with sequence similarity 198, member B |
chr3_-_58196688 | 1.62 |
ENST00000486455.1
|
DNASE1L3
|
deoxyribonuclease I-like 3 |
chr19_-_49552006 | 1.61 |
ENST00000391869.3
|
CGB1
|
chorionic gonadotropin, beta polypeptide 1 |
chr17_-_14683517 | 1.58 |
ENST00000379640.1
|
AC005863.1
|
AC005863.1 |
chr11_+_64879317 | 1.56 |
ENST00000526809.1
ENST00000279263.7 ENST00000524986.1 ENST00000534371.1 ENST00000540748.1 ENST00000525385.1 ENST00000345348.5 ENST00000531321.1 ENST00000529414.1 ENST00000526085.1 ENST00000530750.1 |
TM7SF2
|
transmembrane 7 superfamily member 2 |
chr15_+_96876340 | 1.52 |
ENST00000453270.2
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
chr1_+_16083154 | 1.48 |
ENST00000375771.1
|
FBLIM1
|
filamin binding LIM protein 1 |
chr3_-_58196939 | 1.47 |
ENST00000394549.2
ENST00000461914.3 |
DNASE1L3
|
deoxyribonuclease I-like 3 |
chr9_-_129884902 | 1.46 |
ENST00000373417.1
|
ANGPTL2
|
angiopoietin-like 2 |
chr9_-_129885010 | 1.46 |
ENST00000373425.3
|
ANGPTL2
|
angiopoietin-like 2 |
chr11_+_7618413 | 1.44 |
ENST00000528883.1
|
PPFIBP2
|
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
chrX_+_135278908 | 1.43 |
ENST00000539015.1
ENST00000370683.1 |
FHL1
|
four and a half LIM domains 1 |
chr12_-_86230315 | 1.42 |
ENST00000361228.3
|
RASSF9
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 |
chr11_+_108093559 | 1.40 |
ENST00000278616.4
|
ATM
|
ataxia telangiectasia mutated |
chr2_+_179149636 | 1.36 |
ENST00000409631.1
|
OSBPL6
|
oxysterol binding protein-like 6 |
chr2_-_208489275 | 1.31 |
ENST00000272839.3
ENST00000426075.1 |
METTL21A
|
methyltransferase like 21A |
chr2_+_109223595 | 1.31 |
ENST00000410093.1
|
LIMS1
|
LIM and senescent cell antigen-like domains 1 |
chr2_-_208489707 | 1.30 |
ENST00000448007.2
ENST00000432416.1 ENST00000411432.1 |
METTL21A
|
methyltransferase like 21A |
chr5_-_112630598 | 1.30 |
ENST00000302475.4
|
MCC
|
mutated in colorectal cancers |
chr1_-_211752073 | 1.29 |
ENST00000367001.4
|
SLC30A1
|
solute carrier family 30 (zinc transporter), member 1 |
chr5_-_73937244 | 1.29 |
ENST00000302351.4
ENST00000510316.1 ENST00000508331.1 |
ENC1
|
ectodermal-neural cortex 1 (with BTB domain) |
chr17_-_7531121 | 1.26 |
ENST00000573566.1
ENST00000269298.5 |
SAT2
|
spermidine/spermine N1-acetyltransferase family member 2 |
chr12_-_52585765 | 1.24 |
ENST00000313234.5
ENST00000394815.2 |
KRT80
|
keratin 80 |
chr2_-_89247338 | 1.23 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
chr1_+_43291220 | 1.23 |
ENST00000372514.3
|
ERMAP
|
erythroblast membrane-associated protein (Scianna blood group) |
chr5_+_78532003 | 1.22 |
ENST00000396137.4
|
JMY
|
junction mediating and regulatory protein, p53 cofactor |
chr7_+_22766766 | 1.21 |
ENST00000426291.1
ENST00000401651.1 ENST00000258743.5 ENST00000420258.2 ENST00000407492.1 ENST00000401630.3 ENST00000406575.1 |
IL6
|
interleukin 6 (interferon, beta 2) |
chr12_-_27167233 | 1.19 |
ENST00000535819.1
ENST00000543803.1 ENST00000535423.1 ENST00000539741.1 ENST00000343028.4 ENST00000545600.1 ENST00000543088.1 |
TM7SF3
|
transmembrane 7 superfamily member 3 |
chr1_+_229440129 | 1.18 |
ENST00000366688.3
|
SPHAR
|
S-phase response (cyclin related) |
chr2_-_158732340 | 1.17 |
ENST00000539637.1
ENST00000413751.1 ENST00000434821.1 ENST00000424669.1 |
ACVR1
|
activin A receptor, type I |
chr3_-_114343039 | 1.17 |
ENST00000481632.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
chrX_+_72223352 | 1.15 |
ENST00000373521.2
ENST00000538388.1 |
PABPC1L2B
|
poly(A) binding protein, cytoplasmic 1-like 2B |
chr16_+_67207838 | 1.14 |
ENST00000566871.1
ENST00000268605.7 |
NOL3
|
nucleolar protein 3 (apoptosis repressor with CARD domain) |
chr3_+_25469802 | 1.14 |
ENST00000330688.4
|
RARB
|
retinoic acid receptor, beta |
chr19_+_1248547 | 1.13 |
ENST00000586757.1
ENST00000300952.2 |
MIDN
|
midnolin |
chrX_+_135279179 | 1.12 |
ENST00000370676.3
|
FHL1
|
four and a half LIM domains 1 |
chr8_-_29120580 | 1.12 |
ENST00000524189.1
|
KIF13B
|
kinesin family member 13B |
chr7_-_30518387 | 1.12 |
ENST00000222823.4
ENST00000419601.1 |
NOD1
|
nucleotide-binding oligomerization domain containing 1 |
chr19_+_35485682 | 1.11 |
ENST00000599564.1
|
GRAMD1A
|
GRAM domain containing 1A |
chr11_-_66445219 | 1.11 |
ENST00000525754.1
ENST00000531969.1 ENST00000524637.1 ENST00000531036.2 ENST00000310046.4 |
RBM4B
|
RNA binding motif protein 4B |
chrX_-_72299258 | 1.11 |
ENST00000453389.1
ENST00000373519.1 |
PABPC1L2A
|
poly(A) binding protein, cytoplasmic 1-like 2A |
chr16_+_67207872 | 1.09 |
ENST00000563258.1
ENST00000568146.1 |
NOL3
|
nucleolar protein 3 (apoptosis repressor with CARD domain) |
chr19_-_39322497 | 1.09 |
ENST00000221418.4
|
ECH1
|
enoyl CoA hydratase 1, peroxisomal |
chr1_-_17380630 | 1.09 |
ENST00000375499.3
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip) |
chr17_-_7082861 | 1.07 |
ENST00000269299.3
|
ASGR1
|
asialoglycoprotein receptor 1 |
chr2_-_43266680 | 1.06 |
ENST00000425212.1
ENST00000422351.1 ENST00000449766.1 |
AC016735.2
|
AC016735.2 |
chr12_-_6665200 | 1.06 |
ENST00000336604.4
ENST00000396840.2 ENST00000356896.4 |
IFFO1
|
intermediate filament family orphan 1 |
chr18_-_53253323 | 1.04 |
ENST00000540999.1
ENST00000563888.2 |
TCF4
|
transcription factor 4 |
chr6_-_31864977 | 1.03 |
ENST00000395728.3
ENST00000375528.4 |
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2 |
chr6_+_159590423 | 1.02 |
ENST00000297267.9
ENST00000340366.6 |
FNDC1
|
fibronectin type III domain containing 1 |
chr12_-_8088871 | 1.02 |
ENST00000075120.7
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3 |
chr17_+_38497640 | 1.00 |
ENST00000394086.3
|
RARA
|
retinoic acid receptor, alpha |
chr6_-_8102714 | 1.00 |
ENST00000502429.1
ENST00000429723.2 ENST00000507463.1 ENST00000379715.5 |
EEF1E1
|
eukaryotic translation elongation factor 1 epsilon 1 |
chr18_-_53253112 | 1.00 |
ENST00000568673.1
ENST00000562847.1 ENST00000568147.1 |
TCF4
|
transcription factor 4 |
chr5_+_154320623 | 0.99 |
ENST00000523037.1
ENST00000265229.8 ENST00000439747.3 ENST00000522038.1 |
MRPL22
|
mitochondrial ribosomal protein L22 |
chr2_-_69870747 | 0.96 |
ENST00000409068.1
|
AAK1
|
AP2 associated kinase 1 |
chr7_+_135611542 | 0.96 |
ENST00000416501.1
|
AC015987.2
|
AC015987.2 |
chrX_+_149531524 | 0.96 |
ENST00000370401.2
|
MAMLD1
|
mastermind-like domain containing 1 |
chr5_+_175298573 | 0.96 |
ENST00000512824.1
|
CPLX2
|
complexin 2 |
chr8_-_124286495 | 0.95 |
ENST00000297857.2
|
ZHX1
|
zinc fingers and homeoboxes 1 |
chr4_+_71600144 | 0.93 |
ENST00000502653.1
|
RUFY3
|
RUN and FYVE domain containing 3 |
chr8_-_124286735 | 0.93 |
ENST00000395571.3
|
ZHX1
|
zinc fingers and homeoboxes 1 |
chr2_+_109237717 | 0.93 |
ENST00000409441.1
|
LIMS1
|
LIM and senescent cell antigen-like domains 1 |
chr14_-_65769392 | 0.92 |
ENST00000555736.1
|
CTD-2509G16.5
|
CTD-2509G16.5 |
chr12_-_15104040 | 0.91 |
ENST00000541644.1
ENST00000545895.1 |
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr18_-_52989525 | 0.89 |
ENST00000457482.3
|
TCF4
|
transcription factor 4 |
chr3_+_25469724 | 0.89 |
ENST00000437042.2
|
RARB
|
retinoic acid receptor, beta |
chr3_+_97868170 | 0.88 |
ENST00000437310.1
|
OR5H14
|
olfactory receptor, family 5, subfamily H, member 14 |
chr1_+_196912902 | 0.87 |
ENST00000476712.2
ENST00000367415.5 |
CFHR2
|
complement factor H-related 2 |
chr1_+_196788887 | 0.87 |
ENST00000320493.5
ENST00000367424.4 ENST00000367421.3 |
CFHR1
CFHR2
|
complement factor H-related 1 complement factor H-related 2 |
chr12_-_68696652 | 0.87 |
ENST00000539972.1
|
MDM1
|
Mdm1 nuclear protein homolog (mouse) |
chr1_-_55089191 | 0.87 |
ENST00000302250.2
ENST00000371304.2 |
FAM151A
|
family with sequence similarity 151, member A |
chr2_-_86790593 | 0.86 |
ENST00000263856.4
ENST00000409225.2 |
CHMP3
|
charged multivesicular body protein 3 |
chr3_-_49722523 | 0.86 |
ENST00000448220.1
|
MST1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
chr2_+_179184955 | 0.85 |
ENST00000315022.2
|
OSBPL6
|
oxysterol binding protein-like 6 |
chr4_-_110723194 | 0.84 |
ENST00000394635.3
|
CFI
|
complement factor I |
chr13_-_33112823 | 0.83 |
ENST00000504114.1
|
N4BP2L2
|
NEDD4 binding protein 2-like 2 |
chr4_-_110723335 | 0.83 |
ENST00000394634.2
|
CFI
|
complement factor I |
chr1_+_159557607 | 0.82 |
ENST00000255040.2
|
APCS
|
amyloid P component, serum |
chr2_-_86790472 | 0.82 |
ENST00000409727.1
|
CHMP3
|
charged multivesicular body protein 3 |
chr16_+_28875126 | 0.81 |
ENST00000359285.5
ENST00000538342.1 |
SH2B1
|
SH2B adaptor protein 1 |
chr15_+_39873268 | 0.81 |
ENST00000397591.2
ENST00000260356.5 |
THBS1
|
thrombospondin 1 |
chr7_-_107642348 | 0.80 |
ENST00000393561.1
|
LAMB1
|
laminin, beta 1 |
chr1_+_110754094 | 0.79 |
ENST00000369787.3
ENST00000413138.3 ENST00000438661.2 |
KCNC4
|
potassium voltage-gated channel, Shaw-related subfamily, member 4 |
chr2_-_113999260 | 0.79 |
ENST00000468980.2
|
PAX8
|
paired box 8 |
chr7_+_101460882 | 0.77 |
ENST00000292535.7
ENST00000549414.2 ENST00000550008.2 ENST00000546411.2 ENST00000556210.1 |
CUX1
|
cut-like homeobox 1 |
chr4_-_110723134 | 0.77 |
ENST00000510800.1
ENST00000512148.1 |
CFI
|
complement factor I |
chr11_+_66624527 | 0.76 |
ENST00000393952.3
|
LRFN4
|
leucine rich repeat and fibronectin type III domain containing 4 |
chr1_+_201979645 | 0.75 |
ENST00000367284.5
ENST00000367283.3 |
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
chr16_-_31228680 | 0.75 |
ENST00000302964.3
|
PYDC1
|
PYD (pyrin domain) containing 1 |
chr14_+_88852059 | 0.75 |
ENST00000045347.7
|
SPATA7
|
spermatogenesis associated 7 |
chr12_-_95510743 | 0.74 |
ENST00000551521.1
|
FGD6
|
FYVE, RhoGEF and PH domain containing 6 |
chr7_-_32931623 | 0.73 |
ENST00000452926.1
|
KBTBD2
|
kelch repeat and BTB (POZ) domain containing 2 |
chr18_-_19284724 | 0.73 |
ENST00000580981.1
ENST00000289119.2 |
ABHD3
|
abhydrolase domain containing 3 |
chr5_+_134074231 | 0.72 |
ENST00000514518.1
|
CAMLG
|
calcium modulating ligand |
chrX_+_28605516 | 0.72 |
ENST00000378993.1
|
IL1RAPL1
|
interleukin 1 receptor accessory protein-like 1 |
chr2_-_70475701 | 0.72 |
ENST00000282574.4
|
TIA1
|
TIA1 cytotoxic granule-associated RNA binding protein |
chr22_-_29784519 | 0.71 |
ENST00000357586.2
ENST00000356015.2 ENST00000432560.2 ENST00000317368.7 |
AP1B1
|
adaptor-related protein complex 1, beta 1 subunit |
chr9_+_139981379 | 0.71 |
ENST00000371589.4
|
MAN1B1
|
mannosidase, alpha, class 1B, member 1 |
chr20_+_54933971 | 0.71 |
ENST00000371384.3
ENST00000437418.1 |
FAM210B
|
family with sequence similarity 210, member B |
chr22_+_50354104 | 0.70 |
ENST00000360612.4
|
PIM3
|
pim-3 oncogene |
chr1_-_154458520 | 0.70 |
ENST00000486773.1
|
SHE
|
Src homology 2 domain containing E |
chr8_+_21911054 | 0.70 |
ENST00000519850.1
ENST00000381470.3 |
DMTN
|
dematin actin binding protein |
chr17_-_7082668 | 0.69 |
ENST00000573083.1
ENST00000574388.1 |
ASGR1
|
asialoglycoprotein receptor 1 |
chr10_+_76586348 | 0.69 |
ENST00000372724.1
ENST00000287239.4 ENST00000372714.1 |
KAT6B
|
K(lysine) acetyltransferase 6B |
chr12_-_14849470 | 0.69 |
ENST00000261170.3
|
GUCY2C
|
guanylate cyclase 2C (heat stable enterotoxin receptor) |
chr10_+_112257596 | 0.68 |
ENST00000369583.3
|
DUSP5
|
dual specificity phosphatase 5 |
chr18_-_53255766 | 0.68 |
ENST00000566286.1
ENST00000564999.1 ENST00000566279.1 ENST00000354452.3 ENST00000356073.4 |
TCF4
|
transcription factor 4 |
chr1_-_234667504 | 0.67 |
ENST00000421207.1
ENST00000435574.1 |
RP5-855F14.1
|
RP5-855F14.1 |
chr20_+_3776371 | 0.65 |
ENST00000245960.5
|
CDC25B
|
cell division cycle 25B |
chrX_+_135251835 | 0.64 |
ENST00000456445.1
|
FHL1
|
four and a half LIM domains 1 |
chr11_+_3876859 | 0.63 |
ENST00000300737.4
|
STIM1
|
stromal interaction molecule 1 |
chr5_+_175298674 | 0.63 |
ENST00000514150.1
|
CPLX2
|
complexin 2 |
chr6_-_107077347 | 0.63 |
ENST00000369063.3
ENST00000539449.1 |
RTN4IP1
|
reticulon 4 interacting protein 1 |
chr2_+_69240511 | 0.62 |
ENST00000409349.3
|
ANTXR1
|
anthrax toxin receptor 1 |
chr1_-_246670519 | 0.62 |
ENST00000388985.4
ENST00000490107.1 |
SMYD3
|
SET and MYND domain containing 3 |
chr17_-_27503770 | 0.62 |
ENST00000533112.1
|
MYO18A
|
myosin XVIIIA |
chr2_-_220083076 | 0.61 |
ENST00000295750.4
|
ABCB6
|
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
chr3_+_56591184 | 0.60 |
ENST00000422222.1
ENST00000394672.3 ENST00000326595.7 |
CCDC66
|
coiled-coil domain containing 66 |
chr2_-_70475730 | 0.59 |
ENST00000445587.1
ENST00000433529.2 ENST00000415783.2 |
TIA1
|
TIA1 cytotoxic granule-associated RNA binding protein |
chr8_+_124084899 | 0.59 |
ENST00000287380.1
ENST00000309336.3 ENST00000519418.1 ENST00000327098.5 ENST00000522420.1 ENST00000521676.1 ENST00000378080.2 |
TBC1D31
|
TBC1 domain family, member 31 |
chr1_+_222817629 | 0.59 |
ENST00000340535.7
|
MIA3
|
melanoma inhibitory activity family, member 3 |
chr16_-_47495170 | 0.58 |
ENST00000320640.6
ENST00000544001.2 |
ITFG1
|
integrin alpha FG-GAP repeat containing 1 |
chr20_-_46415297 | 0.58 |
ENST00000467815.1
ENST00000359930.4 |
SULF2
|
sulfatase 2 |
chr10_+_80828774 | 0.58 |
ENST00000334512.5
|
ZMIZ1
|
zinc finger, MIZ-type containing 1 |
chr13_-_30424821 | 0.57 |
ENST00000380680.4
|
UBL3
|
ubiquitin-like 3 |
chr19_+_41117770 | 0.57 |
ENST00000601032.1
|
LTBP4
|
latent transforming growth factor beta binding protein 4 |
chr21_+_17442799 | 0.55 |
ENST00000602580.1
ENST00000458468.1 ENST00000602935.1 |
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr2_+_65663812 | 0.55 |
ENST00000606978.1
ENST00000377977.3 ENST00000536804.1 |
AC074391.1
|
AC074391.1 |
chr6_-_85474219 | 0.55 |
ENST00000369663.5
|
TBX18
|
T-box 18 |
chr17_-_4806369 | 0.55 |
ENST00000293780.4
|
CHRNE
|
cholinergic receptor, nicotinic, epsilon (muscle) |
chr15_+_42696992 | 0.55 |
ENST00000561817.1
|
CAPN3
|
calpain 3, (p94) |
chr5_-_176433350 | 0.54 |
ENST00000377227.4
ENST00000377219.2 |
UIMC1
|
ubiquitin interaction motif containing 1 |
chr6_+_79577189 | 0.54 |
ENST00000369940.2
|
IRAK1BP1
|
interleukin-1 receptor-associated kinase 1 binding protein 1 |
chr7_-_38948774 | 0.53 |
ENST00000395969.2
ENST00000414632.1 ENST00000310301.4 |
VPS41
|
vacuolar protein sorting 41 homolog (S. cerevisiae) |
chr4_-_152682129 | 0.52 |
ENST00000512306.1
ENST00000508611.1 ENST00000515812.1 ENST00000263985.6 |
PET112
|
PET112 homolog (yeast) |
chr7_-_94285402 | 0.52 |
ENST00000428696.2
ENST00000445866.2 |
SGCE
|
sarcoglycan, epsilon |
chr6_+_155537771 | 0.52 |
ENST00000275246.7
|
TIAM2
|
T-cell lymphoma invasion and metastasis 2 |
chr19_-_8809139 | 0.51 |
ENST00000324436.3
|
ACTL9
|
actin-like 9 |
chr11_+_118230287 | 0.51 |
ENST00000252108.3
ENST00000431736.2 |
UBE4A
|
ubiquitination factor E4A |
chr3_+_14989186 | 0.50 |
ENST00000435454.1
ENST00000323373.6 |
NR2C2
|
nuclear receptor subfamily 2, group C, member 2 |
chr7_-_105332084 | 0.50 |
ENST00000472195.1
|
ATXN7L1
|
ataxin 7-like 1 |
chr20_+_3776936 | 0.50 |
ENST00000439880.2
|
CDC25B
|
cell division cycle 25B |
chr1_-_53387386 | 0.49 |
ENST00000467988.1
ENST00000358358.5 ENST00000371522.4 |
ECHDC2
|
enoyl CoA hydratase domain containing 2 |
chr8_-_120685608 | 0.49 |
ENST00000427067.2
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
chr4_+_71859156 | 0.49 |
ENST00000286648.5
ENST00000504730.1 ENST00000504952.1 |
DCK
|
deoxycytidine kinase |
chr17_+_3323862 | 0.48 |
ENST00000291231.1
|
OR3A3
|
olfactory receptor, family 3, subfamily A, member 3 |
chr1_+_152758690 | 0.48 |
ENST00000368771.1
ENST00000368770.3 |
LCE1E
|
late cornified envelope 1E |
chr17_+_75137460 | 0.48 |
ENST00000587820.1
|
SEC14L1
|
SEC14-like 1 (S. cerevisiae) |
chr15_-_52404921 | 0.48 |
ENST00000561198.1
ENST00000260442.3 |
BCL2L10
|
BCL2-like 10 (apoptosis facilitator) |
chr8_-_100905925 | 0.48 |
ENST00000518171.1
|
COX6C
|
cytochrome c oxidase subunit VIc |
chr3_+_183894566 | 0.48 |
ENST00000439647.1
|
AP2M1
|
adaptor-related protein complex 2, mu 1 subunit |
chr5_+_134074191 | 0.47 |
ENST00000297156.2
|
CAMLG
|
calcium modulating ligand |
chr8_+_11666649 | 0.47 |
ENST00000528643.1
ENST00000525777.1 |
FDFT1
|
farnesyl-diphosphate farnesyltransferase 1 |
chrX_+_16668278 | 0.46 |
ENST00000380200.3
|
S100G
|
S100 calcium binding protein G |
chr1_-_47069955 | 0.46 |
ENST00000341183.5
ENST00000496619.1 |
MKNK1
|
MAP kinase interacting serine/threonine kinase 1 |
chr11_+_120207787 | 0.45 |
ENST00000397843.2
ENST00000356641.3 |
ARHGEF12
|
Rho guanine nucleotide exchange factor (GEF) 12 |
chr5_+_180650271 | 0.45 |
ENST00000351937.5
ENST00000315073.5 |
TRIM41
|
tripartite motif containing 41 |
chr19_+_7011509 | 0.45 |
ENST00000377296.3
|
AC025278.1
|
Uncharacterized protein |
chr6_+_73331918 | 0.44 |
ENST00000402622.2
ENST00000355635.3 ENST00000403813.2 ENST00000414165.2 |
KCNQ5
|
potassium voltage-gated channel, KQT-like subfamily, member 5 |
chr16_+_47495201 | 0.44 |
ENST00000566044.1
ENST00000455779.1 |
PHKB
|
phosphorylase kinase, beta |
chr12_+_58013693 | 0.44 |
ENST00000320442.4
ENST00000379218.2 |
SLC26A10
|
solute carrier family 26, member 10 |
chr16_-_57520378 | 0.44 |
ENST00000340099.4
|
DOK4
|
docking protein 4 |
chr2_-_65593784 | 0.44 |
ENST00000443619.2
|
SPRED2
|
sprouty-related, EVH1 domain containing 2 |
chr12_+_6494285 | 0.44 |
ENST00000541102.1
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3) |
chr7_+_129007964 | 0.44 |
ENST00000460109.1
ENST00000474594.1 ENST00000446212.1 |
AHCYL2
|
adenosylhomocysteinase-like 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 9.4 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
1.0 | 5.8 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.9 | 2.7 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
0.9 | 2.6 | GO:0021558 | trochlear nerve development(GO:0021558) auditory receptor cell fate determination(GO:0042668) negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of pro-B cell differentiation(GO:2000974) |
0.8 | 3.3 | GO:0009956 | radial pattern formation(GO:0009956) |
0.7 | 2.2 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
0.7 | 5.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.6 | 3.1 | GO:1905040 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.6 | 3.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.5 | 12.9 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.5 | 1.4 | GO:1904882 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.4 | 1.7 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.4 | 1.7 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.4 | 1.2 | GO:2000366 | hepatic immune response(GO:0002384) regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
0.4 | 1.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.4 | 1.4 | GO:0009447 | putrescine catabolic process(GO:0009447) |
0.3 | 1.0 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.3 | 0.8 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.3 | 1.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.3 | 1.0 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.2 | 1.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.7 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.2 | 1.5 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.2 | 0.6 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.2 | 2.0 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 0.8 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.2 | 1.1 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 0.7 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.2 | 1.3 | GO:0097501 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.2 | 0.6 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
0.2 | 3.1 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.1 | 0.6 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.1 | 1.1 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.1 | 1.7 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 3.7 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 2.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.9 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 0.4 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.1 | 0.9 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.1 | 1.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.7 | GO:0006789 | bilirubin conjugation(GO:0006789) |
0.1 | 2.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.7 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.1 | 1.7 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.1 | 1.4 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.7 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
0.1 | 0.3 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.1 | 1.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 1.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.4 | GO:0003095 | pressure natriuresis(GO:0003095) |
0.1 | 0.3 | GO:0061009 | common bile duct development(GO:0061009) |
0.1 | 1.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
0.1 | 0.6 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.5 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.1 | 0.3 | GO:2001162 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
0.1 | 0.6 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.5 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.4 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.1 | 0.3 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.3 | GO:0002424 | plasmacytoid dendritic cell activation(GO:0002270) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) regulation of restriction endodeoxyribonuclease activity(GO:0032072) |
0.1 | 0.2 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
0.1 | 0.7 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.1 | 0.5 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.4 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.1 | 0.7 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 4.0 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.5 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 1.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.9 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 1.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.7 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.8 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.9 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 1.6 | GO:0030728 | ovulation(GO:0030728) |
0.1 | 0.8 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.2 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.1 | 0.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 3.0 | GO:0097009 | energy homeostasis(GO:0097009) |
0.1 | 0.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.4 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 3.2 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.0 | 0.1 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.0 | 0.6 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.2 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.0 | 1.0 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 1.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 2.6 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 2.0 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.2 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 1.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.4 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 1.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 1.0 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.1 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.0 | 1.5 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.5 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.0 | 0.3 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.0 | 0.9 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 1.8 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.7 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 4.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.4 | GO:0046415 | urate transport(GO:0015747) urate metabolic process(GO:0046415) |
0.0 | 0.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.5 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
0.0 | 0.3 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.9 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.0 | 0.2 | GO:1902001 | carnitine shuttle(GO:0006853) fatty acid transmembrane transport(GO:1902001) |
0.0 | 0.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 1.2 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.3 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.1 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.0 | 0.0 | GO:0046880 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of luteinizing hormone secretion(GO:0033686) regulation of follicle-stimulating hormone secretion(GO:0046880) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.6 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.8 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.0 | 1.3 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 2.1 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.0 | 0.7 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.3 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 1.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.9 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 1.4 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 2.7 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.7 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.8 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.1 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.0 | 0.1 | GO:0021678 | third ventricle development(GO:0021678) |
0.0 | 0.8 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.0 | 0.7 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.2 | GO:0003416 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
0.0 | 1.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 3.0 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.0 | 0.2 | GO:0030238 | male sex determination(GO:0030238) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 9.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.4 | 1.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 1.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 3.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 0.8 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.2 | 0.8 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.2 | 1.6 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.2 | 1.4 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 1.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 6.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 2.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 1.4 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 2.7 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.3 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.1 | 0.7 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 2.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.2 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
0.1 | 0.5 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.7 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 1.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 1.0 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.6 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.2 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.0 | 0.1 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.0 | 0.7 | GO:0031095 | spectrin-associated cytoskeleton(GO:0014731) platelet dense tubular network membrane(GO:0031095) |
0.0 | 0.4 | GO:0031906 | late endosome lumen(GO:0031906) |
0.0 | 2.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 4.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 1.2 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 5.7 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 1.4 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 0.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 1.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 2.5 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 2.3 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.1 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.0 | 0.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.9 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.3 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 1.0 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.8 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.2 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.4 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.0 | GO:0031783 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.7 | 2.2 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.6 | 6.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.5 | 1.6 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.4 | 1.1 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.3 | 1.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.3 | 3.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 3.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.3 | 3.6 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.3 | 0.8 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 1.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 1.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 2.2 | GO:0035877 | death effector domain binding(GO:0035877) |
0.2 | 1.8 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.2 | 0.6 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.2 | 1.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.6 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.2 | 0.5 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
0.2 | 3.0 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 1.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.7 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.1 | 0.8 | GO:0039552 | RIG-I binding(GO:0039552) |
0.1 | 1.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 4.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.4 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.1 | 0.5 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.6 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.1 | 0.5 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.1 | 0.8 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.1 | 1.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.4 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.1 | 0.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 1.7 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.1 | 0.4 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 0.7 | GO:0001093 | TFIIB-class transcription factor binding(GO:0001093) |
0.1 | 0.4 | GO:0004335 | galactokinase activity(GO:0004335) |
0.1 | 0.9 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.2 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
0.1 | 0.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 1.7 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 1.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.3 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.6 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 1.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 1.5 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 1.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 1.5 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 1.1 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.4 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.3 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.1 | 0.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.3 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.0 | 0.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.5 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 17.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 2.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.1 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.0 | 0.7 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 1.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 2.7 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
0.0 | 3.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 1.1 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 2.4 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) |
0.0 | 0.2 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.0 | 2.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.5 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.5 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 3.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.8 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 9.6 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.2 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.4 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 2.0 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.4 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.5 | GO:0035173 | histone kinase activity(GO:0035173) lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 1.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.9 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.0 | 0.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 1.8 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.4 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.7 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 18.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 2.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 2.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 2.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 4.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 1.2 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 1.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 2.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 4.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 1.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 1.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 1.8 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 1.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 1.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 1.0 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.5 | PID ATM PATHWAY | ATM pathway |
0.0 | 1.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 1.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 9.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 2.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 3.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 5.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.7 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 2.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 3.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 2.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 1.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 1.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 3.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 1.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 1.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 1.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 1.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 2.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 1.0 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 2.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 1.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.2 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 1.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 1.0 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |